copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
RYTELO® (imetelstat) HCP Website | RYTELOHCP RYTELO® (imetelstat) is indicated for treatment of adult patients with low- to intermediate-1 risk myelodysplastic syndromes (MDS) with transfusion-dependent anemia
Rytelo: Uses, Dosage, Side Effects, Warnings - Drugs. com Rytelo (imetelstat) is an injectable telomerase inhibitor that may be used to treat adults with low- to intermediate-1 risk myelodysplastic syndromes (MDS) with transfusion-dependent anemia
Rytelo | European Medicines Agency (EMA) Myelodysplastic syndromes are rare, and Rytelo was designated an ‘orphan medicine’ (a medicine used in rare diseases) on 27 July 2020 Further information on the orphan designation can be found on the EMA website Rytelo contains the active substance imetelstat
Imetelstat - Wikipedia Imetelstat, sold under the brand name Rytelo, is an anti-cancer medication used for the treatment of myelodysplastic syndromes with transfusion-dependent anemia [1] Imetelstat is an oligonucleotide telomerase inhibitor [1][2][3] By blocking telomerase activity, imetelstat causes telomere shortening, inhibits the proliferation of malignant stem and progenitor cells and induces cell death
label - Food and Drug Administration RYTELO (imetelstat) for injection is a sterile, preservative-free, white to off-white or slightly yellow lyophilized powder for intravenous infusion after reconstitution and dilution